Sun 3 August 2014, Financial Times

Private equity eyes drug brands purchase

By Andrew Ward, Arash Massoudi and Anne-Sylvaine Chassany
KKR and Warburg Pincus are among those said to be exploring a $10bn plan to buy hundreds of older drug brands from GSK and Sanofi and merge them

Similar articles

(what's this?)

ordered by similarity (order by date)